CLPT ClearPoint Neuro
- 11.650
- -1.770-13.19%
- 11.667
- +0.017+0.15%
ClearPoint Neuro News
ClearPoint Neuro | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
ClearPoint Neuro | 8-K: Current report
ClearPoint Neuro | 424B5: Prospectus
ClearPoint Neuro | 10-Q: Quarterly report
ClearPoint Neuro | 8-K: ClearPoint Neuro Reports Third Quarter 2024 Results
ClearPoint Neuro | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.50%)
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer SABRA MAZIN
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Director Girin Pascal E R
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Director Richards Timothy T.
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Director LIAU LINDA M.
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Director FLETCHER R JOHN
ClearPoint Neuro | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-PTC Therapeutics, Inc.(3.24%)
ClearPoint Neuro | 8-K: Current report
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer STIGALL L. JEREMY
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer D'Alessandro Danilo
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer BURNETT JOSEPH MICHAEL
ClearPoint Neuro | 10-Q: Q2 2024 Earnings Report
ClearPoint Neuro | 8-K: ClearPoint Neuro Reports Second Quarter 2024 Results
ClearPoint Neuro | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(1.3%)
ClearPoint Neuro | 4: Statement of changes in beneficial ownership of securities-Officer SABRA MAZIN
Analysis
Price Target
No Data
No Data
